Pancreatic cancer is one of the most lethal malignant diseases in gastrointestinal system that only about 15-20% of the patients are potential candidates for resection at diagnostic stage. However, with the advent of neoadjuvant chemotherapy and advancement of surgical skills, patients with locally advanced pancreatic cancer (LAPC), which were deemed initially unresectable, have undergone margin negative radical resection. Here, we present a case of a patient with LAPC who was previously treated with neoadjuvant FOLFIRINOX and underwent pancreaticoduodenectomy combined with vascular resection after preoperative percutaneous transhepatic portal vein stent placement to relieve of portal vein obliteration. The patient recovered without any complication and was discharged on day 8 postoperatively.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7691189PMC
http://dx.doi.org/10.14701/ahbps.2020.24.4.551DOI Listing

Publication Analysis

Top Keywords

portal vein
16
pancreatic cancer
12
neoadjuvant chemotherapy
8
combined vascular
8
preoperative percutaneous
8
percutaneous transhepatic
8
transhepatic portal
8
vein stent
8
stent placement
8
locally advanced
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!